Sudarshan Sukhani of s2analytics.com told CNBC-TV18, “JP Associates and Ranbaxy, both of them are now simple avoids. JP Associates is actually a sell on rallies. Yesterday there was a small rally day before and we said okay let us sell in that strength. The charts are broken down so badly that the entire up move is now in difficulty.”
He further added, “The same thing has happened with Ranbaxy. This market repeatedly for the last 8 to 10 months has been rewarding strength. We should stay with strength only, stay with strong stocks whether it is HUL or Sun Pharma or whatever.”Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
